Assembly Biosciences (ASMB) Enterprise Value (2010 - 2026)

Assembly Biosciences' Enterprise Value history runs 17 years deep, the most recent figure standing at -$226.6 million for Q1 2026.

• In Q1 2026, Enterprise Value fell 148.94% year-over-year to -$226.6 million; the TTM figure through Mar 2026 stood at -$226.6 million (down 148.94% YoY), while the FY2025 annual figure was -$248.1 million, down 121.37% from the prior year.
• Enterprise Value was -$226.6 million for Q1 2026 at Assembly Biosciences, up from -$248.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$46.2 million in Q3 2023 to a low of -$248.1 million in Q4 2025.
• Historically, Enterprise Value has averaged -$120.7 million across 5 years, with a median of -$109.2 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Enterprise Value surged 57.47% in 2023, then plunged 148.94% in 2026.
• A 5-year view of Enterprise Value shows it stood at -$91.6 million in 2022, then sank by 42.18% to -$130.2 million in 2023, then grew by 13.95% to -$112.1 million in 2024, then plunged by 121.37% to -$248.1 million in 2025, then grew by 8.67% to -$226.6 million in 2026.
• The last three Enterprise Value figures came in at -$226.6 million (Q1 2026), -$248.1 million (Q4 2025), and -$232.6 million (Q3 2025), per Business Quant data.